- Home
- BEATW vs EFT Comparison
BEATW vs EFT Comparison
Compare BEATW & EFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEATW
- EFT
- Stock Information
- Founded
- BEATW N/A
- EFT 2004
- Country
- BEATW United States
- EFT United States
- Employees
- BEATW 20
- EFT N/A
- Industry
- BEATW Retail: Computer Software & Peripheral Equipment
- EFT Finance Companies
- Sector
- BEATW Technology
- EFT Finance
- Exchange
- BEATW Nasdaq
- EFT Nasdaq
- Market Cap
- BEATW N/A
- EFT N/A
- IPO Year
- BEATW 2021
- EFT N/A
- Fundamental
- Price
- BEATW $0.57
- EFT $13.16
- Analyst Decision
- BEATW
- EFT
- Analyst Count
- BEATW 0
- EFT 0
- Target Price
- BEATW N/A
- EFT N/A
- AVG Volume (30 Days)
- BEATW N/A
- EFT 100.8K
- Earning Date
- BEATW N/A
- EFT 01-01-0001
- Dividend Yield
- BEATW N/A
- EFT 10.63%
- EPS Growth
- BEATW N/A
- EFT N/A
- EPS
- BEATW N/A
- EFT 1.73
- Revenue
- BEATW N/A
- EFT N/A
- Revenue This Year
- BEATW N/A
- EFT N/A
- Revenue Next Year
- BEATW N/A
- EFT N/A
- P/E Ratio
- BEATW N/A
- EFT $7.62
- Revenue Growth
- BEATW N/A
- EFT N/A
- 52 Week Low
- BEATW N/A
- EFT $11.10
- 52 Week High
- BEATW N/A
- EFT $13.44
- Technical
- Relative Strength Index (RSI)
- BEATW N/A
- EFT 48.56
- Support Level
- BEATW N/A
- EFT $13.06
- Resistance Level
- BEATW N/A
- EFT $13.27
- Average True Range (ATR)
- BEATW 0.00
- EFT 0.17
- MACD
- BEATW 0.00
- EFT 0.01
- Stochastic Oscillator
- BEATW 0.00
- EFT 68.00
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.